Bio-Rad(BIO) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Press Release Bio-Rad Reports First-Quarter 2025 Financial Results HERCULES, Calif.—May 1, 2025 -- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced financial results for the first quarter ended March 31, 2025. Norman Schwartz, Bio-Rad's Chairman and Chief Executive Officer, stated: "We navigated a highly dynamic first quarter that became progressively more challenging, yet we delivered solid margins thr ...